
beta-Amyrin palmitate
CAS No. 5973-06-8
beta-Amyrin palmitate( —— )
Catalog No. M31009 CAS No. 5973-06-8
Beta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 376 | In Stock |
![]() ![]() |
50MG | Get Quote | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Namebeta-Amyrin palmitate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBeta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity.
-
DescriptionBeta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity. Beta-Amyrin palmitate, like mianserin and imipramine, reduces the duration of immobility of mice significantly in a dose-dependent manner (5, 10 and 20 mg kg-1); (1)Beta-Amyrin palmitate or mianserin elicits a dose-related reduction in locomotor activity of mice and antagonizes locomotor stimulation induced by methamphetamine, imipramine increases locomotor activity and potentiates methamphetamine-induced hyperactivity; (2)Beta-Amyrin palmitate shows no effect on reserpine-induced hypothermia, whilst mianserin (10 mg kg-1) and imipramine (10 and 20 mg kg-1) antagonizes the reserpine-induced effect; (3)Beta-amyrin palmitate has similar properties in some respects to mianserin and might possess a sedative action.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLDL | HMG-CoA Reductase | Adrenergic Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5973-06-8
-
Formula Weight665.1
-
Molecular FormulaC46H80O2
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J Pharm Pharmacol. 1993 Jun;45(6):545-50.
molnova catalog



related products
-
Polymyxin B
Polymyxin B, an antibiotic, combats Gram-negative infections through high-affinity binding to the bacterial wall's lipopolysaccharides (LPS), neutralizing endotoxin effects and inducing bacterial cell death by enhancing permeability.
-
GPX4-IN-5
GPX4-IN-5 is a small molecule covalent GPX4 inhibitor (IC50: 0.12 μM) with antitumour activity.
-
Datopotamab
Datopotamab (CDP7657) is a TROP2-targeting antibody that is a naked antibody to Datopotamab deruxtecan and can be used to synthesize active antibody conjugators (Datopotamab deruxtecan).